Rare diseases
Investigational molecules
Locations
Back to Greece1 004 clinical trials in Piraeus, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
GreeceStudy of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
GreeceStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
GreeceStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
GreeceStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
GreeceStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
GreeceStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
GreeceStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
GreeceStudy of tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)
GreeceStudy of subcutaneous nivolumab with ipilimumab and chemotherapy in previously untreated patients with metastatic or recurrent non-small cell lung cancer
GreeceStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
GreeceLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
GreeceThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, particularly in non-small cell lung cancer and novel therapeutic combinations. Studies include investigations of targeted therapies and immunotherapy approaches.
Innovative research combining standard treatments with new therapeutic agents to improve patient outcomes.
Research initiatives targeting heart failure prevention and stroke prevention in patients with atrial fibrillation. Studies evaluate new therapeutic approaches for managing cardiovascular risks.
Trials focusing on both preventive measures and treatment of established cardiovascular conditions.
Clinical investigations in multiple myeloma and related blood disorders, exploring combination therapies and novel treatment approaches for patients with various blood-related conditions.
Studies examining innovative therapeutic combinations for improved patient outcomes.
Research focusing on treating Crohn's Disease and other inflammatory conditions, evaluating new therapeutic options and combination treatments for better disease management.
Studies aimed at improving treatment outcomes in chronic inflammatory diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
